Tarsus Pharmaceuticals TARS
NASDAQ TARS
$73.31 -2.15 (-2.84%)
As of: Oct 2, 2026 · 3:42 PM EDT

Tarsus Pharmaceuticals (TARS) Long-Term Investments (2022 - 2026)

Updated

Tarsus Pharmaceuticals (TARS) reported Long-Term Investments of $6.68 million for Q2 2026, up 122.7% from $3 million a year earlier and up 72.7% from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Long-Term Investments (2022 - 2026) Analysis & Trends

At the end of FY2025, Tarsus Pharmaceuticals posted Long-Term Investments of $3.87 million, up 29.0% from FY2024.

  • Long-Term Investments has increased for three consecutive years, with a three-year compound annual growth rate of 118.5% (FY2022 to FY2025).
  • By year, Long-Term Investments came in at $3 million in FY2024 (+375.4%), $631,000 in FY2023 (+70.1%) and $371,000 in FY2022.
  • The Q2 2026 figure ranks as the highest quarterly Long-Term Investments in data going back to Q2 2022.
  • Year over year, Long-Term Investments has now increased in each of the last three quarters, with growth averaging 92.7% over the last six quarters.
  • Across the past five years, year-over-year growth in Long-Term Investments ran from 0.0% in Q2 2025 to 831.7% in Q2 2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $3.87 million (Q1 2026), $3.87 million (Q4 2025) and $3 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Tarsus Pharmaceuticals 3.40 Bn 2.35 Bn 161.80 Mn 6.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.68 Mn
Mar 31, 2026 3.87 Mn
Dec 31, 2025 3.87 Mn
Sep 30, 2025 3.00 Mn
Jun 30, 2025 3.00 Mn
Mar 31, 2025 3.00 Mn
Dec 31, 2024 3.00 Mn
Sep 30, 2024 3.00 Mn
Jun 30, 2024 3.00 Mn
Dec 31, 2023 631,000.00
Sep 30, 2023 210,000.00
Jun 30, 2023 322,000.00
Mar 31, 2023 306,000.00
Dec 31, 2022 371,000.00
Sep 30, 2022 157,000.00
Jun 30, 2022 169,000.00
API Access

Tarsus Pharmaceuticals Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=TARS&period=max&api_key=YOUR_API_KEY